MUC - Latest News
BlackRock MuniHoldings California Quality Fund, Inc. (MUC), operates in Financial Services / Asset Management, trades on NYSE.
Market capitalization stands near $1.01B.
The article list below shows the most recent MUC headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent MUC Headlines
ArriVent Announces IND Clearance for Novel Tetravalent MUC16/NaPi2b Targeting ADC ARR-002 with Initial Focus in Ovarian and Endometrial Cancers
globenewswire.com - May 7, 2026
NEWTOWN SQUARE, Pa. , May 07, 2026 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc.
MUC: Has Seen A Great Return, With More Gains Likely To Come
seekingalpha.com - Apr 11, 2026
BlackRock MuniHoldings California Quality Fund offers targeted California muni exposure, appealing primarily to state residents seeking tax-advantaged
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026
prnewswire.com - Apr 10, 2026
MUC16 is the highest-expressing ADC target in ovarian cancer, at least two-fold higher than other emerging targets MUC16 is highly and stably expresse
BlackRock MuniHoldings California Quality Fund, Inc. $MUC Position Increased by Allspring Global Investments Holdings LLC
defenseworld.net - Apr 7, 2026
Allspring Global Investments Holdings LLC increased its position in shares of BlackRock MuniHoldings California Quality Fund, Inc. (NYSE: MUC) by 17.
ArriVent to Present Two Preclinical Posters on the EGFR Inhibitor Firmonertinib and on the Novel dual-target MUC16/NaPi2b Tetravalent ADC ARR-002 at the 2026 AACR Annual Meeting
globenewswire.com - Mar 17, 2026
NEWTOWN SQUARE, Pa. , March 17, 2026 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc.
Frequently asked MUC news questions
- What is the latest MUC news headline?
- The most recent MUC headline (May 7, 2026) is "ArriVent Announces IND Clearance for Novel Tetravalent MUC16/NaPi2b Targeting ADC ARR-002 with Initial Focus in Ovarian and Endometrial Cancers". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the MUC news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What MUC news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual MUC options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.